Sagimet CEO David Happel says oral denifanstat could sharply cut antibiotic use in acne and be used before patients ever need ...

The 2026 Pharmacy Benefit Management Institute Annual National Conference was held Sept. 10-11 in Orlando, Florida. Here is a ...

Sagimet Biosciences’ denifanstat oral acne pill shows rapid, sustained lesion cuts and higher clear-skin rates in phase 3, ...

The lawsuit targets the Global Benchmark for Efficient Drug Pricing (GLOBE) Model, a mandatory model CMS finalized last week ...

Sagimet Biosciences has begun screening patients for a U.S. phase 3 trial of denifanstat, an investigational once-daily oral ...

Pills that rival biologics, weight-loss drugs paired with psoriasis treatment and a phase 3 win for a personalized mRNA ...

The CEO and founder of a digital behavior company has advice for health plans considering asynchronous behavioral health ...

A risk score built from 31 small RNA molecules found in blood was linked to lung cancer up to 10 years before diagnosis in a ...

Direct-to-consumer drug programs hold the promise of cheaper GLP-1s and other drugs, but buying drugs outside insurance benefits may be more costly— and risky — in the long run. More Americans are ...

In this conversation, Alison Pritchard, Ph.D., explains how ADHD and sleep problems can form a cycle in children and shares findings from ‘What Matters to Caregivers of Youth Wi ...

New guidelines for acute low back pain favors self-care, NSAIDs, physical therapy and acupuncture over routine imaging and first-line opioids. Imaging and opioids should not be first-line treatment ...

Fewer than one in five young people with first episode psychosis filled enough antipsychotic prescriptions to be considered ...